Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-01-17 Sale |
2025-01-22 6:05 pm |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
20,148 | $11.2 | $225,680 | 262,608 (Direct) |
View |
2024-07-10 Sale |
2024-07-12 6:37 pm |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
10,911 | $11.56 | $126,131 | 282,115 (Direct) |
View |
2024-01-17 Sale |
2024-01-19 5:19 pm |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
9,781 | $17.23 | $168,527 | 194,605 (Direct) |
View |
2023-07-17 Sale |
2023-07-19 8:23 pm |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
19,771 | $18.01 | $356,058 | 203,999 (Direct) |
View |
2023-03-30 Sale |
2023-04-03 6:48 pm |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
9,960 | $26.52 | $264,148 | 148,470 (Direct) |
View |
2023-01-23 Sale |
2023-01-25 9:00 pm |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
30,000 | $35 | $1,050,000 | 236,219 (Direct) |
View |
2022-12-20 Sale |
2022-12-21 9:32 pm |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
9,643 | $19.1 | $184,204 | 80,424 (Direct) |
View |
2020-12-01 Sale |
2020-12-02 8:00 pm |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
18,734 | $30 | $562,035 | 253,416 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-23 Option Award |
2025-01-27 6:01 pm |
N/A 2035-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
169,950 | $0 | 432,558 (Direct) |
View |
2024-07-09 Option Award |
2024-07-11 4:54 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
21,313 | $0 | 293,026 (Direct) |
View |
2024-05-02 Exercise |
2024-05-06 06:02 am |
N/A 2029-01-24 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
21,000 | $0 | 347,760 (Direct) |
View |
2024-05-02 Exercise |
2024-05-06 06:02 am |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
21,000 | $2.08 | 347,760 (Direct) |
View |
2024-01-23 Option Award |
2024-01-24 4:57 pm |
N/A 2034-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
165,750 | $0 | 360,355 (Direct) |
View |
2023-07-14 Option Award |
2023-07-18 7:17 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
38,750 | $0 | 223,770 (Direct) |
View |
2023-06-13 Exercise |
2023-06-14 6:14 pm |
N/A 2029-01-24 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
30,750 | $0 | 282,067 (Direct) |
View |
2023-06-13 Exercise |
2023-06-14 6:14 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
30,750 | $2.08 | 282,067 (Direct) |
View |
2023-06-09 Exercise |
2023-06-12 6:19 pm |
N/A 2029-01-24 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
5,800 | $0 | 282,067 (Direct) |
View |
2023-06-09 Exercise |
2023-06-12 6:19 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
5,800 | $2.08 | 282,067 (Direct) |
View |
2023-03-29 Option Award |
2023-03-31 5:56 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
19,375 | $0 | 158,430 (Direct) |
View |
2023-01-25 Option Award |
2023-01-27 7:15 pm |
N/A 2033-01-24 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
130,200 | $0 | 214,624 (Direct) |
View |
2023-01-23 Exercise |
2023-01-25 9:00 pm |
N/A 2029-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
30,000 | $0 | 236,219 (Direct) |
View |
2023-01-23 Exercise |
2023-01-25 9:00 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
12,500 | $2.08 | 236,219 (Direct) |
View |
2023-01-23 Exercise |
2023-01-25 9:00 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
17,500 | $6.22 | 236,219 (Direct) |
View |
2022-12-22 Exercise |
2022-12-27 4:30 pm |
N/A 2029-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
4,000 | $0 | 230,521 (Direct) |
View |
2022-12-22 Exercise |
2022-12-27 4:30 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
4,000 | $2.08 | 230,521 (Direct) |
View |
2022-12-19 Option Award |
2022-12-21 9:32 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
19,375 | $0 | 80,424 (Direct) |
View |
2022-01-26 Option Award |
2022-02-02 8:15 pm |
N/A 2032-01-25 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
124,000 | $0 | 124,000 (Direct) |
View |
2021-09-03 Exercise |
2021-09-03 6:27 pm |
N/A 2029-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
20,000 | $0 | 217,718 (Direct) |
View |
2021-09-03 Exercise |
2021-09-03 6:27 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
20,000 | $2.08 | 217,718 (Direct) |
View |
2021-03-05 Exercise |
2021-03-05 8:51 pm |
N/A 2029-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
20,000 | $0 | 217,718 (Direct) |
View |
2021-03-05 Exercise |
2021-03-05 8:51 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
20,000 | $2.08 | 217,718 (Direct) |
View |
2021-01-23 Option Award |
2021-01-26 8:00 pm |
N/A 2031-01-22 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
74,250 | $0 | 74,250 (Direct) |
View |
2020-12-21 Exercise |
2020-12-23 8:00 pm |
N/A 2029-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
4,500 | $0 | 217,718 (Direct) |
View |
2020-12-21 Exercise |
2020-12-23 8:00 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
4,500 | $2.08 | 217,718 (Direct) |
View |
2020-12-01 Exercise |
2020-12-02 8:00 pm |
N/A 2029-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
18,734 | $0 | 253,416 (Direct) |
View |
2020-12-01 Exercise |
2020-12-02 8:00 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
11,591 | $2.08 | 253,416 (Direct) |
View |
2020-12-01 Exercise |
2020-12-02 8:00 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
7,143 | $6.22 | 253,416 (Direct) |
View |
2020-04-30 Exercise |
2020-06-09 9:08 pm |
N/A 2029-01-23 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
19,300 | $0 | 299,472 (Direct) |
View |
2020-02-28 Option Award |
2020-06-09 9:08 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
27,322 | $13.08 | 299,472 (Direct) |
View |
2020-03-31 Option Award |
2020-06-09 9:08 pm |
N/A 2030-03-30 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
42,841 | $0 | 299,472 (Direct) |
View |
2020-06-05 Conversion |
2020-06-09 9:08 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
31,143 | $0 | 299,472 (Direct) |
View |
2020-04-30 Exercise |
2020-06-09 9:08 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
19,300 | $2.08 | 299,472 (Direct) |
View |
Ownership |
2020-06-02 9:07 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
0 | $0 | 272,150 (Direct) |
View |